SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012401
Filing Date
2016-04-21
Accepted
2016-04-21 08:03:16
Documents
3
Period of Report
2016-06-08
Effectiveness Date
2016-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228333zdef14a.htm DEF 14A 578421
2 G22932BEI001.GIF g22932bei001.gif GRAPHIC 62807
3 G22932BEI002.GIF g22932bei002.gif GRAPHIC 35757
  Complete submission text file 0001047469-16-012401.txt   715724
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 161582653
SIC: 2835 In Vitro & In Vivo Diagnostic Substances